Edition:
United Kingdom

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.50USD
22 Feb 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.50
Open
$2.49
Day's High
$2.50
Day's Low
$2.45
Volume
7,623
Avg. Vol
21,981
52-wk High
$7.15
52-wk Low
$2.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.92 45.97
P/E Low - Last 5 Yrs. -- 23.79 24.37
Beta 1.69 0.90 0.89
Price to Sales (TTM) 0.26 3.98 5.77
Price to Book (MRQ) -- 4.84 5.41
Price to Tangible Book (MRQ) -- 5.66 6.98
Price to Cash Flow (TTM) -- 23.02 23.42
% Owned Institutions 21.30 1.25 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) -- 45.86 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -6.61 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago -17.36 4.72 5.59
Sales - 5 Yr. Growth Rate 18.37 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 53.78 16.64 19.65
EPS (TTM) vs TTM 1 Yr. Ago 29.25 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate 41.15 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.67 2.11 2.18
Current Ratio (MRQ) 0.75 2.89 2.97
LT Debt to Equity (MRQ) -- 9.91 12.22
Total Debt to Equity (MRQ) -- 13.93 16.52
Interest Coverage (TTM) -9.29 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.21 55.11 54.70
Gross Margin - 5 Yr. Avg. 64.57 52.40 52.42
EBITD Margin (TTM) 4.02 -- --
EBITD - 5 Yr. Avg -0.57 18.51 10.86
Operating Margin (TTM) -93.55 14.36 4.64
Operating Margin - 5 Yr. Avg. -56.18 14.42 6.26
Pre-Tax Margin (TTM) -120.18 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.73 6.60
Net Profit Margin (TTM) -120.56 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -65.04 11.07 2.91
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 733,508 948,737,942 855,668,157
Net Income/Employee (TTM) -884,286 111,622,123 100,655,595
Receivable Turnover (TTM) 2.90 5.62 5.78
Inventory Turnover (TTM) 4.45 2.58 3.35
Asset Turnover (TTM) 0.42 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.40 11.45 10.98
Return on Assets - 5 Yr. Avg. -23.23 12.98 12.37
Return on Investment (TTM) -74.47 14.90 14.43
Return on Investment - 5 Yr. Avg. -31.36 16.98 16.18
Return on Equity (TTM) -- 16.41 16.13
Return on Equity - 5 Yr. Avg. -138.91 18.08 17.47
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.69%
# of Holders: 40
Total Shares Held: 2,501,727
3 Mo. Net Change: 87,657
# New Positions: 2
# Closed Positions: 4
# Increased Positions: 7
# Reduced Positions: 11
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.